Literature DB >> 1617921

Factors affecting nonadherence with antibiotics.

R Sanson-Fisher1, J Bowman, S Armstrong.   

Abstract

Nonadherence with antibiotic therapy has profound implications both for patient health and the health care system that bears the financial costs incurred. Significant levels of nonadherence with antibiotic prescriptions have been demonstrated. Of the many proposed variables involved, those that are potentially modifiable relate to aspects of the doctor-patient interaction and drug regimen. Despite the potential for intervention with these variables, there have been very few methodologically sound studies examining their effect on adherence with either medications generally or antibiotics specifically. Only two studies were located that had tested the effectiveness of reduced complexity of antibiotic dosage schedules. The results suggest that the less complex the schedule, the greater is the adherence. Both practitioners and patients must be encouraged to use and accept simpler dosage schedules, preferably once-daily schedules wherever possible. The paucity of well-controlled studies to date highlights the need for further research evaluating intervention strategies that utilize variations in dosage schedule and elements of the doctor-patient interaction to improve adherence with antibiotic medications.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1617921     DOI: 10.1016/0732-8893(92)90136-h

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  10 in total

1.  Knowledge, beliefs, and use of prescribed antibiotic medications among low-socioeconomic African Americans.

Authors:  T L Kandakai; J H Price; S K Telljohann; M Holiday-Goodman
Journal:  J Natl Med Assoc       Date:  1996-05       Impact factor: 1.798

Review 2.  Rational prescribing of antibacterials in ambulatory children.

Authors:  J E Hoppe
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

Review 3.  Concurrent gonococcal and chlamydial infection: how best to treat.

Authors:  A J Robinson; G L Ridgway
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 4.  Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.

Authors:  S S Patel; J A Balfour; H M Bryson
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

5.  Prevalence of inappropriate use behaviors of antibiotics and related factors among chinese antibiotic users: an online cross-sectional survey.

Authors:  Lei Qiu; Hui Li; Xiaoxv Yin; Yanhong Gong; Na Sun; Dandan Li; Jianxiong Wu; Jing Wang
Journal:  BMC Infect Dis       Date:  2022-08-13       Impact factor: 3.667

6.  Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001.

Authors:  Carolyn M Greene; Jennita Reefhuis; Christina Tan; Anthony E Fiore; Susan Goldstein; Michael J Beach; Stephen C Redd; David Valiante; Gregory Burr; James Buehler; Robert W Pinner; Eddy Bresnitz; Beth P Bell
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

7.  Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence.

Authors:  Colin W Shepard; Montse Soriano-Gabarro; Elizabeth R Zell; James Hayslett; Susan Lukacs; Susan Goldstein; Stephanie Factor; Joshua Jones; Renee Ridzon; Ian Williams; Nancy Rosenstein
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

8.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16

9.  Factors affecting therapeutic compliance: A review from the patient's perspective.

Authors:  Jing Jin; Grant Edward Sklar; Vernon Min Sen Oh; Shu Chuen Li
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

10.  Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001.

Authors:  Mariaelena D Jefferds; Kayla Laserson; Alicia M Fry; Sharon Roy; James Hayslett; Laurence Grummer-Strawn; Laura Kettel-Khan; Anne Schuchat
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.